Adult Neurogenesis and Psychiatric Disorders

Cold Spring Harbor Perspectives in Biology
Eunchai KangGuo-Li Ming

Abstract

Psychiatric disorders continue to be among the most challenging disorders to diagnose and treat because there is no single genetic or anatomical locus that is causative for the disease. Current treatments are often blunt tools used to ameliorate the most severe symptoms, at the risk of disrupting functional neural systems. There is a critical need to develop new therapeutic strategies that can target circumscribed functional or anatomical domains of pathology. Adult hippocampal neurogenesis may be one such domain. Here, we review the evidence suggesting that adult hippocampal neurogenesis plays a role in emotional regulation and forms of learning and memory that include temporal and spatial memory encoding and context discrimination, and that its dysregulation is associated with psychiatric disorders, such as affective disorders, schizophrenia, and drug addiction. Further, adult neurogenesis has proven to be an effective model to investigate basic processes of neuronal development and converging evidence suggests that aberrant neural development may be an etiological factor, even in late-onset diseases. Constitutive neurogenesis in the hippocampus of the mature brain reflects large-scale plasticity unique to this region and cou...Continue Reading

References

May 1, 1992·Trends in Neurosciences·G F KoobL Stinus
Jul 1, 1987·Archives of General Psychiatry·D R Weinberger
Jun 1, 1965·The Journal of Comparative Neurology·J Altman, G D Das
Aug 1, 1995·Pharmacology, Biochemistry, and Behavior·R B KanarekJ Przypek
Feb 1, 1995·Alcoholism, Clinical and Experimental Research·E V SullivanA Pfefferbaum
Aug 1, 1994·The Journal of Nervous and Mental Disease·A E PulverD Housman
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y I ShelineM W Vannier
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·S M Lawrie, S S Abukmeil
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G CsernanskyM I Miller
Nov 11, 1998·Nature Medicine·P S ErikssonF H Gage
Feb 20, 1999·Archives of General Psychiatry·A G CardnoR M Murray
Apr 10, 1999·Archives of General Psychiatry·I AgartzD W Hommer
May 8, 1999·Scientific American·G Kempermann, F H Gage
May 20, 1999·Biological Psychiatry·G RajkowskaC A Stockmeier
Oct 26, 1999·Trends in Neurosciences·R Spanagel, F Weiss
Oct 26, 1999·Archives of General Psychiatry·K C MurphyM J Owen
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·H van PraagF H Gage
Dec 22, 1999·Biological Psychiatry·E Gould, P Tanapat
Jan 5, 2000·The American Journal of Psychiatry·I C WrightE T Bullmore
Feb 25, 2000·Biological Psychiatry·M S GeorgeJ C Ballenger
May 18, 2000·Human Molecular Genetics·J K MillarD J Porteous
Jun 7, 2000·Proceedings of the National Academy of Sciences of the United States of America·A J EischE J Nestler
Jun 23, 2000·Biological Psychiatry·T M MadsenA Tingström
Jul 13, 2000·Molecular Psychiatry·B L JacobsF H Gage
Sep 15, 2000·Journal of Neurochemistry·G ChenH K Manji
Oct 4, 2000·Archives of General Psychiatry·R M Sapolsky
Feb 13, 2001·Biological Psychiatry·L C Konick, L Friedman
Apr 11, 2001·Seminars in Clinical Neuropsychiatry·G Villarreal, C Y King
Oct 25, 2001·Proceedings of the National Academy of Sciences of the United States of America·B CzéhE Fuchs
Apr 4, 2002·Neuroreport·Guoqiang XingRobert Post
Jul 3, 2002·Nature Reviews. Molecular Cell Biology·Edwin R Chapman
Aug 10, 2002·The European Journal of Neuroscience·Johan HellstenAnders Tingström
Nov 16, 2002·Progress in Brain Research·Amelia J Eisch
Nov 20, 2002·Journal of Neurochemistry·Kimberly Nixon, Fulton T Crews

❮ Previous
Next ❯

Citations

Jun 15, 2016·Annual Review of Cell and Developmental Biology·Jonas Frisén
Oct 19, 2016·Neurotoxicology and Teratology·Eunchai KangC David Mintz
Apr 1, 2017·International Journal of Molecular Sciences·Verica Vasic, Mirko H H Schmidt
Jun 21, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chantelle E TerrillionMikhail V Pletnikov
Feb 16, 2018·Journal of Psychopharmacology·Jordi OlloquequiAntoni Camins
Feb 23, 2020·Epigenomics·Andrew M ShafikPeng Jin
Sep 28, 2017·Cell and Tissue Research·Christina CataveroJuan Song
Mar 28, 2017·Reviews in the Neurosciences·Ashutosh KumarSankat Mochan
Jul 30, 2020·Stem Cells and Development·Rui S RodriguesSara Xapelli
Jan 10, 2018·Frontiers in Molecular Neuroscience·Franciele F ScaranteAlline C Campos
May 17, 2018·Brain Plasticity·Marlen Knobloch
Aug 29, 2018·Brain Plasticity·Natalie E PatzlaffXinyu Zhao
Jan 23, 2018·Frontiers in Molecular Neuroscience·Tuan Leng TayMarie-Eve Tremblay
May 26, 2018·PloS One·Ping ZhangXiao-Qing Tang
Dec 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Juthamart ManeenetAnake Kijjoa
Feb 24, 2018·Frontiers in Neuroscience·Hanaa MalloulSaadia Ba-M'hamed
Aug 29, 2018·Brain Plasticity·Yoshio Takashima, Chitra D Mandyam
Sep 12, 2018·Journal of Neuroinflammation·Svetlana ZonisVera Chesnokova
Aug 2, 2018·Physiological Reviews·Ariel A Di NardoAlain Prochiantz
Oct 26, 2018·Frontiers in Behavioral Neuroscience·Wenxiang QingQin Liao
Jun 7, 2019·Neural Regeneration Research·Hannah C LeesonMichael W Weible
Oct 20, 2020·Brain Pathology·Omar Mossad, Daniel Erny
Nov 12, 2020·Expert Review of Clinical Pharmacology·Johanna KeelerJanet Treasure
Dec 4, 2020·Cerebral Cortex·Huaigui LiuChunshui Yu
Dec 11, 2020·Journal of Neurochemistry·Oleg V Podgorny, Natalia V Gulyaeva

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.